Chembio Diagnostic Systems, Inc. Company Profile

05:26 EDT 22nd September 2018 | BioPortfolio

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Chembio’s focus is on developing, manufacturing and marketing tests for the rapid, simple and cost-effective detection of HIV, Tuberculosis (human and veterinary), and certain other Neglected Diseases. Chembio has a proven commitment toward ensuring sustainable supplies of high quality rapid tests to those who need them by using innovative, socially responsible strategies. Chembio Diagnostic Systems, Inc. operates a cGMP/QS (Good Manufacturing Facility/Quality Systems) manufacturing facility that is registered with the US FDA (Food and Drug Administration). The facility includes dedicated cGMP process manufacturing, Quality Control and R&D laboratories. The company manufacturers class II and class III in vitro diagnostic devices. Chembio ’s HIV assays have been incorporated into the World Health Organization (WHO) Bulk Procurement Scheme and the USAID blanket Waiver List which allows them to be procured with US government funds. In 2006, Former President Bill Clinton announced that his foundation’s HIV/AIDS Initiative negotiated new pricing agreements to lower the prices of HIV diagnostics and two antiretrovirals (ARVs). These products and pricing include Chembio’s STAT-PAK™ HIV 1 / 2 Dipstick. The Foundation’s Procurement Consortium currently includes 50 developing countries around the world.


3661 Horseblock Road
New York
United States of America


Phone: 1 631 924 1135
Fax: 1 631 924 6033

News Articles [640 Associated News Articles listed on BioPortfolio]

Chembio Dx appoints new board member

Mary Lake Polan, a professor at the Yale School of Medicine, has been tapped by Chembio Diagnostic Systems to serve on its bo -More- 

FIND, Chembio partner to explore point-of-care HCV testing

Chembio Diagnostic Systems' Dual Path Platform technology will be used to assess the feasibility of a rapid hepatitis C virus -More- 

Chembio, LumiraDx to develop Dx tests for global health threats

Chembio Diagnostics and LumiraDx entered into a collaborative agreement that will involve developing point-of-care diagnostic -More- 

Chembio Diagnostics Announces Agreement with Bio-Manguinhos to Commercialize Point-of-Care Tests for Dengue, Zika and Chikungunya in Brazil

Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today announced the signing of a long-term agreement with Bio-Manguinhos to c...

Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q2 Results - Earnings Call Transcript

Chembio Diagnostics' (CEMI) CEO John Sperzel on Q1 2018 Results - Earnings Call Transcript

Chembio Diagnostics' (CEMI) CEO John Sperzel on Q4 2017 Results - Earnings Call Transcript

Chembio Diagnostic, Inc. CEMI Medical Equipment Deals and Alliances Profile [Report Updated: 13022018] Prices from USD $250

SummaryChembio Diagnostic, Inc. Chembio develops, manufactures, markets and licenses pointofcare diagnostic POCs tests for the detection of infectious diseases. The company offers products to prevent ...

Drugs and Medications [24 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Oxygen Support Systems Inc]


Derma ice burn relief with aloe vera [S & S Primeline Chemical Systems]


Oxygen [Medical Comfort Systems Inc]

Oxygen Label

Xenon xe 133 gasfor diagnostic use [Bristol-Myers Squibb]


Glucagen hypokit [Novo Nordisk]

These highlights do not include all the information needed to use GlucaGen safely and effectively. See full prescribing information for GlucaGen.GlucaGen  (glucagon [rDNA origin] for injection)Initia...

PubMed Articles [2056 Associated PubMed Articles listed on BioPortfolio]

The diagnostic and cellularity yield of reverse bevel versus fork-tip fine needle biopsy.

Two new systems with a novel tip (Procore™ and SharkCore™) have been introduced for ultrasound-guided fine needle biopsy (US-FNB). Direct comparison of the diagnostic yield of these needles in the...

Implications of DSM-5 for the diagnosis of pediatric eating disorders.

The aim of the study was to compare the DSM-IV, DSM-5, and ICD-10 eating disorders (ED) nomenclatures to assess their value in the classification of pediatric eating disorders. We investigated the pre...

Mind the overlap: how system problems contribute to cognitive failure and diagnostic errors.

Background Traditionally, research has examined systems- and cognitive-based sources of diagnostic error as individual entities. However, half of all errors have origins in both domains. Methods We co...

Reliability of DSM and empirically derived prototype diagnosis for mood, anxiety and personality disorders.

Prominent psychiatric diagnostic systems such as the DSM-IV and ICD-10 have shown low reliability in clinical practice. An alternative approach to classification of psychiatric disorders is prototype ...

Mortality of patients examined at a diagnostic centre: A matched cohort study.

'Diagnostic Centres' has been established to provide a diagnostic pathway for patients with non-specific, serious symptoms that could be cancer. As little is known about the prognosis, we aimed to 1) ...

Clinical Trials [3174 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in ...

Comparative Study of Postprocessing Imaging Systems for Diminutive Colonic Polyps

Several novel imaging technologies are currently used for detection and differentiation of colonic polyps during colonoscopy, such as NBI (Olympus), FICE (Fujinon), and i-Scan (Pentax). ...

Medical Evaluation of Scanner in Coronary Syndrome

Many recent publications have reported encouraging results on diagnostic cardiac multislice CT performance in 1) coronary artery disease, 2) coronary arterial bypass graft potency and 3) i...

Postpartum Immediate Contraception in Cesarean Deliveries-Comparison of Two Intrauterine Systems

To compare two intrauterine systems in order to avoid complications originating from short pregnancy interval and undesired pregnancies in the early postpartum period.

Companies [2388 Associated Companies listed on BioPortfolio]

Chembio Diagnostic Systems Incorporated

Chembio Diagnostic Systems, Inc., is a U.S. biotechnology company located in Medford, New York. The company discovers, develops, manufactures and markets rapid immunodiagnostic tests. Chembio's rapid ...

Chembio Diagnostics

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Ch...

Chembio Diagnostic Systems, Inc.

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Ch...

Natus Medical

Natus' product lines include: Hearing Screening Systems, Hearing Diagnostic Systems, Jaundice Management Products, Newborn Care Products, Data Management Systems, Neurology Diagnostic Systems and Slee...

ONI Medical Systems Inc.

ONI Medical Systems Inc. has developed and marketed dedicated-purpose musculoskeletal MRI systems that exceed the rigorous requirements of diagnostic radiology. With a clear focus...

More Information about "Chembio Diagnostic Systems, Inc." on BioPortfolio

We have published hundreds of Chembio Diagnostic Systems, Inc. news stories on BioPortfolio along with dozens of Chembio Diagnostic Systems, Inc. Clinical Trials and PubMed Articles about Chembio Diagnostic Systems, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chembio Diagnostic Systems, Inc. Companies in our database. You can also find out about relevant Chembio Diagnostic Systems, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...

Corporate Database Quicklinks

Searches Linking to this Company Record